IL1B and cancer: The fact that so many cancer cells displayed immunoreactivity for both proteins implies that a positive feedback mechanism may exist in which IL-1β is secreted by the cancer cell and binds to the receptor on the same cell, activating NF-ĸB, which, in turn, activates iNOS expression (51).